Onconetix, Inc. Pension and Other Postretirement Benefits Cost (Reversal of Cost)
Onconetix, Inc. (ONCO) reported Pension and Other Postretirement Benefits Cost (Reversal of Cost) of -$619.40 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PensionAndOtherPostretirementBenefitExpense · last filed 2026-08-13
- Onconetix, Inc. pension and other postretirement benefits cost (reversal of cost) for the quarter ending 2025-06-30 was $197.13K.
- Onconetix, Inc. pension and other postretirement benefits cost (reversal of cost) for the quarter ending 2025-03-31 was -$89.83K.
- Onconetix, Inc. pension and other postretirement benefits cost (reversal of cost) for fiscal 2025 was -$619.40K.
- Onconetix, Inc. pension and other postretirement benefits cost (reversal of cost) for fiscal 2024 was -$48.42K.
| Period end | Pension and Other Postretirement Benefits Cost (Reversal of Cost) 3 month | Pension and Other Postretirement Benefits Cost (Reversal of Cost) 6 month | Pension and Other Postretirement Benefits Cost (Reversal of Cost) 12 month |
|---|---|---|---|
| 2025-12-31 | -$619.40K 10-K · filed 2026-03-13 | ||
| 2025-06-30 | $197.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $107.30K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$89.83K 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | -$48.42K 10-K · filed 2026-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |